Molecular Partners
MOLN · Switzerland
Share price · MOLN
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Adjusted for stock splits · Data via Databento
Unusual price moves
Days when MOLN's shares moved far more than they usually do, with what was announced that day or the session before. An announcement on the same day does not show that it caused the move. How the days are picked
- 3 Nov 2026-11.2%
Nothing announced by MOLN that day or the session before.
- 28 Sep 2026-10.2%
Nothing announced by MOLN that day or the session before.
- 18 Sep 2026+7.4%
Nothing announced by MOLN that day or the session before.
- 12 Jun 2026+10.8%
Nothing announced by MOLN that day or the session before.
- 22 May 2026+10.0%
Nothing announced by MOLN that day or the session before.
- 30 Apr 2026-4.9%
Nothing announced by MOLN that day or the session before.
- 8 Apr 2026+9.6%
Nothing announced by MOLN that day or the session before.
- 18 Mar 2026+4.7%
- 13 Mar 2026-10.4%
Share of unusual movement by asset
For each asset, the share of MOLN's own-move activity since 2 Jul 2024 that fell on the session of one of the asset's own announcements or the session after it. Large moves count for much more than small ones. A session shared by several assets is split between them. A share is shown once an asset has at least 8 event days; below that, its events are listed instead.
| Asset | Event days | Share of unusual movement |
|---|---|---|
MP0533events and moves
| 3 | shown from 8 days |
| Assets with fewer than 8 event days, together | — | 2% |
| Other company news (earnings, financing, releases naming no asset) | — | 14% |
| Sessions with no dated event | — | 84% |
Assets
(2 total)
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
Quarterly & interim (4)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-Q2 | $0 | $13M | $103M+ $41M short-term inv. | $25M | report ↗ |
Molecular Partners reported revenue of $0M, down 100.0% YoY, R&D spend of $12.98M, down 10.3% YoY, cash and equivalents of $103.39M, and a net loss of $24.72M for Q2 2025.
Figures only: this period's report disclosed no narrative text
View 3 more
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2024-Q2 | $1.7M | $14M | $73M+ $104M short-term inv. | $17M | report ↗ |
| 2023-Q2 | $0.5M | $13M | $71M+ $173M short-term inv. | $18M | report ↗ |
| 2022-Q2 | $12M | $13M | $120M+ $178M short-term inv. | $4.7M | report ↗ |
Annual history (5 years)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $0 | $48M | $104M+ $13M short-term inv. | $19M-$62M operating cash flow | report ↗ |
View 4 more years
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2024-FY | $5.6M | $55M | $71M+ $95M short-term inv. | $15M-$67M operating cash flow | report ↗ |
| 2023-FY | $7.8M | $54M | $80M+ $142M short-term inv. | $17M-$66M operating cash flow | report ↗ |
| 2022-FY | $199M | $53M | $95M+ $174M short-term inv. | —$124M operating cash flow | report ↗ |
| 2021-FY | $10M | $61M | $79M+ $67M short-term inv. | $17M-$99M operating cash flow | report ↗ |
Insider transactions
This company files with the SEC but has no Section 16 insider reports. This is typical for foreign private issuers, which are exempt from Form 4 reporting.
Institutional holders
From SEC Form 13F filings for the quarter ended 2026-03-31 (filed up to 45 days later). 4 reporting institutions held 3.6M shares ($14.2M).
| # | Institution | Shares | Value |
|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,221,494 | $8.8M |
| 2 | BVF INC/IL | 1,353,968 | $5.4M |
| 3 | SmartHarvest Portfolios, LLC | 15,543 | $62K |
| 4 | MORGAN STANLEY | 367 | $1K |